In contrast, Khabaz et al. reported that high Cyclin D1 expression was more prevalent in younger patients (<40 years old) and decreased with age (p = 0.0001), highlighting a potential demographic influence on Cyclin D1 expression in endometrial cancer [11]. Here, CCND1 is linked to endometrial cancer.